{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:22:44Z","timestamp":1791206564865,"version":"4.1.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/ijo.2013.1797","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T13:10:52Z","timestamp":1358946652000},"page":"912-920","source":"Crossref","is-referenced-by-count":27,"title":["FKBP10\/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome"],"prefix":"10.3892","volume":"42","author":[{"given":"MICHAEL C.J.","family":"QUINN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAULINA M.","family":"WOJNAROWICZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMY","family":"PICKETT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIANE M.","family":"PROVENCHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANNE-MARIE","family":"MES-MASSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELAINE C.","family":"DAVIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATRICIA N.","family":"TONIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"key20180107180755_b1-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/sj.onc.1203463","article-title":"Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers","volume":"19","author":"Dion","year":"2000","journal-title":"Oncogene"},{"key":"key20180107180755_b2-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.2910540210","article-title":"Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma","volume":"54","author":"Foulkes","year":"1993","journal-title":"Int J Cancer"},{"key":"key20180107180755_b3-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mc.20096","article-title":"Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1\u2013q25.2","volume":"43","author":"Presneau","year":"2005","journal-title":"Mol Carcinog"},{"key":"key20180107180755_b4-ijo-42-03-0912","first-page":"18656","article-title":"Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer","volume":"40","author":"Wojnarowicz","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107180755_b5-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"TCGA","year":"2011","journal-title":"Nature"},{"key":"key20180107180755_b6-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"e11408","DOI":"10.1371\/journal.pone.0011408","article-title":"Copy number analysis identifies novel interactions between genomic loci in ovarian cancer","volume":"5","author":"Gorringe","year":"2010","journal-title":"PloS One"},{"key":"key20180107180755_b7-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ijc.2910640614","article-title":"Genetic alterations distinguish different types of ovarian tumors","volume":"64","author":"Pieretti","year":"1995","journal-title":"Int J Cancer"},{"key":"key20180107180755_b8-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1593\/neo.08784","article-title":"Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations","volume":"10","author":"Sangha","year":"2008","journal-title":"Neoplasia"},{"key":"key20180107180755_b9-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2008.07.036","article-title":"DNA hypermethylation, Her-2\/neu overexpression and p53 mutations in ovarian carcinoma","volume":"111","author":"Feng","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180107180755_b10-ijo-42-03-0912","first-page":"3324","article-title":"Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women","volume":"8","author":"Rathi","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180107180755_b11-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<829::AID-IJC26>3.0.CO;2-3","article-title":"Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells","volume":"81","author":"Pergolizzi","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107180755_b12-ijo-42-03-0912","first-page":"4973","article-title":"Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells","volume":"59","author":"Bruening","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107180755_b13-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.onc.1206219","article-title":"Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines","volume":"22","author":"Presneau","year":"2003","journal-title":"Oncogene"},{"key":"key20180107180755_b14-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1525-1438.2007.01134.x","article-title":"Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes","volume":"18","author":"Wojnarowicz","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107180755_b15-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.onc.1209821","article-title":"Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p","volume":"26","author":"Cody","year":"2007","journal-title":"Oncogene"},{"key":"key20180107180755_b16-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/mc.20511","article-title":"Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer","volume":"48","author":"Quinn","year":"2009","journal-title":"Mol Carcinog"},{"key":"key20180107180755_b17-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"29336","DOI":"10.1074\/jbc.270.49.29336","article-title":"Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65)","volume":"270","author":"Coss","year":"1995","journal-title":"J Biol Chem"},{"key":"key20180107180755_b18-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3300109","article-title":"Chicken FK506-binding protein, FKBP65, a member of the FKBP family of peptidylprolyl cis-trans isomerases, is only partially inhibited by FK506","volume":"330","author":"Zeng","year":"1998","journal-title":"Biochem J"},{"key":"key20180107180755_b19-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1379\/CSC-118R.1","article-title":"Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin","volume":"10","author":"Patterson","year":"2005","journal-title":"Cell Stress Chaperones"},{"key":"key20180107180755_b20-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1091\/mbc.11.11.3925","article-title":"Developmental regulation of FKBP65. An ER-localized extra-cellular matrix binding-protein","volume":"11","author":"Patterson","year":"2000","journal-title":"Mol Biol Cell"},{"key":"key20180107180755_b21-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"31584","DOI":"10.1074\/jbc.M802535200","article-title":"The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens","volume":"283","author":"Ishikawa","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107180755_b22-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acid Res"},{"key":"key20180107180755_b23-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","article-title":"Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta","volume":"86","author":"Alanay","year":"2010","journal-title":"Am J Hum Genet"},{"key":"key20180107180755_b24-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jbmr.250","article-title":"Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome","volume":"26","author":"Kelley","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key20180107180755_b25-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02767334","article-title":"Concurrent ovarian serous carcinoma and osteogenesis imperfecta","volume":"253","author":"Nishida","year":"1993","journal-title":"Arch Gynecol Obstet"},{"key":"key20180107180755_b26-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-8-152","article-title":"Characterization of three new serous epithelial ovarian cancer cell lines","volume":"8","author":"Ouellet","year":"2008","journal-title":"BMC Cancer"},{"key":"key20180107180755_b27-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"e38541","DOI":"10.1371\/journal.pone.0038541","article-title":"BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis","volume":"7","author":"Le Page","year":"2012","journal-title":"PloS One"},{"key":"key20180107180755_b28-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180107180755_b29-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1038\/sj.onc.1208214","article-title":"Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling","volume":"24","author":"Ouellet","year":"2005","journal-title":"Oncogene"},{"key":"key20180107180755_b30-ijo-42-03-0912","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol Biol"},{"key":"key20180107180755_b31-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/nar\/gkg129","article-title":"The UCSC Genome Browser Database","volume":"31","author":"Karolchik","year":"2003","journal-title":"Nucleic Acid Res"},{"key":"key20180107180755_b32-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-007-9608-6","article-title":"Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families","volume":"108","author":"Arcand","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107180755_b33-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1083\/jcb.140.2.295","article-title":"Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway","volume":"140","author":"Davis","year":"1998","journal-title":"J Cell Biol"},{"key":"key20180107180755_b34-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107180755_b35-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s13277-011-0167-4","article-title":"Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium","volume":"32","author":"Henriksen","year":"2011","journal-title":"Tumour Biol"},{"key":"key20180107180755_b36-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","article-title":"Characterization of four novel epithelial ovarian cancer cell lines","volume":"36","author":"Provencher","year":"2000","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"key20180107180755_b37-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mc.20361","article-title":"Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes","volume":"47","author":"Birch","year":"2008","journal-title":"Mol Carcinog"},{"key":"key20180107180755_b38-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mc.20535","article-title":"Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer","volume":"48","author":"Cody","year":"2009","journal-title":"Mol Carcinog"},{"key":"key20180107180755_b39-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181a3cd38","article-title":"Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer","volume":"19","author":"Manderson","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107180755_b40-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"key20180107180755_b41-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"key":"key20180107180755_b42-ijo-42-03-0912","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","article-title":"Stromal gene expression predicts clinical outcome in breast cancer","volume":"14","author":"Finak","year":"2008","journal-title":"Nat Med"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1797\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:10:24Z","timestamp":1515348624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,23]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/ijo.2013.1797"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1797","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}